Skip to main content
. 2020 Apr 8;22(11):1686–1695. doi: 10.1093/neuonc/noaa083

Table 3.

Disease progression or recurrence in groups A and B

Disease Progression and Recurrence Group A n = 54 Group B n = 38
 Local and metastatic  disease progression 4 2
 Metastatic disease  progression 6 3
 Local recurrence 6 1
 Local and metastatic  recurrence 2 2
 Metastatic recurrence 6 10
 Median time to  disease progression  or recurrence, y (range) 0.56 (0.2–7.3) 1.1 (0.15–6.1)
 Median follow-up, 50%  (95% CI), y 10 (8–13) 8 (5.5–11)